See All Slides - tctmd.com

Slides

Presentation TCT 2014

Ex-Vivo Simulator for Training, Teaching, and Testing of Transcatheter Valve Therapies Based on the Principle of a Passive Beating Heart

Presenter: Devesh Amatya

September 16, 2014

Presentation TCT 2014

Diamondback 360 Coronary Orbital Atherectomy System for Treating De Novo, Severely Calcified Coronary Lesions in Elderly Patients: 1-Year Results from the ORBIT II Trial

Presenter: Arthur Lee

September 16, 2014

Presentation TCT 2014

Evaluation of flow reversal during carotid artery stenting as the first choice for embolic protection - no contraindications!

Presenter: Marius Hornung

September 16, 2014

Presentation TCT 2014

Effect of Cangrelor on Ischemic Endpoints: Further Analyses from CHAMPION PHOENIX

Presenter: Deepak Bhatt

September 16, 2014

Presentation TCT 2014

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

Presenter: Bernard Chevalier

September 16, 2014

Presentation TCT 2014

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year___

Presenter: Georgios Vlachojannis

September 16, 2014

Presentation TCT 2014

The Genetic Basis Of Patent Foramen Ovale

Presenter: Nabil Noureddin

September 16, 2014

Presentation TCT 2014

The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients

Presenter: Christopher Meduri

September 16, 2014

Presentation TCT 2014

Long-term 25 Years Follow-up of Mitral Valvuloplasty with Single Balloon_ Independent Predictors of Survival and Event Free Survival

Presenter: Edison Peixoto

September 16, 2014

Presentation TCT 2014

A New Thin-Strut, Low-Dose, Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating: Safety and Efficacy Clinical Performance of the Inspiron? Stent in___

Presenter: Guy F Prado Jr

September 16, 2014

Advertisement

Slides

Ex-Vivo Simulator for Training, Teaching, and Testing of Transcatheter Valve Therapies Based on the Principle of a Passive Beating Heart

Diamondback 360 Coronary Orbital Atherectomy System for Treating De Novo, Severely Calcified Coronary Lesions in Elderly Patients: 1-Year Results from the ORBIT II Trial

Evaluation of flow reversal during carotid artery stenting as the first choice for embolic protection - no contraindications!

Effect of Cangrelor on Ischemic Endpoints: Further Analyses from CHAMPION PHOENIX

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year___

The Genetic Basis Of Patent Foramen Ovale

The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients

Long-term 25 Years Follow-up of Mitral Valvuloplasty with Single Balloon_ Independent Predictors of Survival and Event Free Survival

A New Thin-Strut, Low-Dose, Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating: Safety and Efficacy Clinical Performance of the Inspiron? Stent in___

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content